Literature DB >> 3625195

Platelet MAO in patients with idiopathic pain disorders.

B G Almay, L von Knorring, L Oreland.   

Abstract

Patients with idiopathic pain syndromes have been compared to healthy volunteers and patients with neurogenic pain syndromes as concerns the activity of the enzyme monoamine oxidase (MAO) in thrombocytes. In both patients with idiopathic pain syndromes and in patients with neurogenic pain syndromes an increased frequency of patients with low platelet MAO activity was found. As low platelet MAO activity has been suggested to reflect low central serotoninergic activity the results are in line with findings of reduced concentrations of the serotonin metabolite 5-HIAA in CSF in patients with idiopathic pain syndromes. The results would also give some support for the suggestion that idiopathic pain syndromes might be a variant of depressive disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3625195     DOI: 10.1007/BF01244345

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  23 in total

1.  Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals--a genetic study.

Authors:  G Oxenstierna; G Edman; L Iselius; L Oreland; S B Ross; G Sedvall
Journal:  J Psychiatr Res       Date:  1986       Impact factor: 4.791

2.  Cerebral monoamines and depression. An investigation with the Probenecid technique.

Authors:  H M van Praag; J Korf; D Schut
Journal:  Arch Gen Psychiatry       Date:  1973-06

3.  "Chronic pain as a variant of depressive disease". A critical reappraisal.

Authors:  D C Turk; P Salovey
Journal:  J Nerv Ment Dis       Date:  1984-07       Impact factor: 2.254

4.  Biological markers for depression in chronic pain.

Authors:  D Blumer; F Zorick; M Heilbronn; T Roth
Journal:  J Nerv Ment Dis       Date:  1982-07       Impact factor: 2.254

5.  idiopathic pain disorder: a critique of pain-prone disorder and a proposal for a revision of the DSM-III category psychogenic pain disorder.

Authors:  J B Williams; R L Spitzer
Journal:  J Nerv Ment Dis       Date:  1982-07       Impact factor: 2.254

6.  Chronic pain as a variant of depressive disease: the pain-prone disorder.

Authors:  D Blumer; M Heilbronn
Journal:  J Nerv Ment Dis       Date:  1982-07       Impact factor: 2.254

7.  Genetics of platelet MAO activity in discordant schizophrenic and normal twins.

Authors:  M A Reveley; A M Reveley; C A Clifford; R M Murray
Journal:  Br J Psychiatry       Date:  1983-06       Impact factor: 9.319

8.  A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. I. Clinical findings.

Authors:  A Aberg-Wistedt
Journal:  Acta Psychiatr Scand       Date:  1982-07       Impact factor: 6.392

9.  Pain as a symptom in depressive disorders and its relationship to platelet monoamine oxidase activity.

Authors:  L von Knorring; C Perris; L Oreland; M Eisemann; U Eriksson; H Perris
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

10.  CSF monoamine metabolites in melancholia.

Authors:  M Asberg; L Bertilsson; B Mårtensson; G P Scalia-Tomba; P Thorén; L Träskman-Bendz
Journal:  Acta Psychiatr Scand       Date:  1984-03       Impact factor: 6.392

View more
  3 in total

1.  Mutational analysis of serotonin receptor genes: HTR3A and HTR3B in fibromyalgia patients.

Authors:  Bernd Frank; Beate Niesler; Brigitta Bondy; Michael Späth; Dieter E Pongratz; Manfred Ackenheil; Christine Fischer; Gudrun Rappold
Journal:  Clin Rheumatol       Date:  2004-05-07       Impact factor: 2.980

Review 2.  Idiopathic pain and depression.

Authors:  L von Knorring; L Ekselius
Journal:  Qual Life Res       Date:  1994-12       Impact factor: 4.147

3.  Common genetic risk factors for psychiatric and simatic disorders.

Authors:  Brigitta Bondy
Journal:  Dialogues Clin Neurosci       Date:  2003-06       Impact factor: 5.986

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.